Publication | Closed Access

Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors

Tumor BiologyNeck CancerCancer-associated VirusMedicinePathologyVirologyHead And Neck CancerGanciclovir AdministrationBiodistribution StudyNeck OncologyOncologyRadiation OncologyTreatment ResistanceCancer ResearchViral OncologyHerpes Simplex Virus Vaccines